Abbott ABT Diagnostic Products — Goodwill, non-deductible
Other segment segments
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's diagnostic products — goodwill, non-deductible.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Abbott's diagnostic products — goodwill, non-deductible?
- Abbott (ABT) reported diagnostic products — goodwill, non-deductible of $14.9B in Q1 2026.
- How has Abbott's diagnostic products — goodwill, non-deductible changed year-over-year?
- Abbott's diagnostic products — goodwill, non-deductible increased by 325.7% year-over-year, from $3.5B to $14.9B.
- What is the long-term trend for Abbott's diagnostic products — goodwill, non-deductible?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — goodwill, non-deductible has grown at a -1.4% compound annual growth rate (CAGR), from $15.1B to $14.3B.
- What does diagnostic products — goodwill, non-deductible mean?
- Acquisition-related intangible value that does not offer tax deduction benefits.
- How do you interpret diagnostic products — goodwill, non-deductible?
- High levels may indicate past aggressive acquisition strategies, while changes reflect impairment testing or new M&A activity.
- How does diagnostic products — goodwill, non-deductible compare across companies?
- Standard accounting metric for companies with significant M&A history.